Navigation Links
MacuSight Expands Management Team With Appointment of Dr. Joel Naor as Chief Medical Officer
Date:2/20/2008

ons he will make to MacuSight and our clinical programs."

Dr. Naor earned his M.D. from the Technion -- Israel Institute of Technology and underwent cornea and external disease training at the University of Toronto where he also obtained his M.Sc. in epidemiology. He holds a Masters of Business Administration from Simon Fraser University in Vancouver.

"I am thrilled to be joining a management team that has an impressive track record in identifying and advancing novel therapeutics in the area of ophthalmology and which is supported by a scientific advisory board of world-renowned experts," said Dr. Naor. "Clearly, we all believe in the great promise that sirolimus holds in treating various ocular diseases and conditions and I am confident in the ability of MacuSight to realize this potential and deliver a much needed therapeutic option to patients."

About MacuSight

MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part of its unique product development philosophy, MacuSight also concentrates on the optimal delivery of these compounds into the eye. By combining its compounds with innovative delivery approaches, the company strives to optimize the efficacy, safety, convenience and cost-effectiveness of its product candidates.

The company's lead development program is centered on advancing sirolimus (rapamycin) as a potential next-generation therapeutic for the treatment and prevention of wet age-related macular degeneration (wet AMD) and the treatment of diabetic macular edema (DME), a manifestation of diabetic retinopathy.


'/>"/>
SOURCE MacuSight, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Veteran Bariatric Surgeon Expands Services to Solano County
2. Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant
3. Convera(R) Expands Advanstar OnLine Business to Vertical Search Covering Pharmaceutical Industry Applications
4. Hondros College Expands School of Nursing to Columbus and Dayton; Students Can Begin LPN Education Almost Immediately
5. Beryl Expands Leadership Team, Adds Senior VP of Product Management and Marketing
6. Anthem Blue Cross and Blue Shield Expands Network of Hospitals to Serve Hoosier Healthwise Members
7. Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
8. HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778
9. HearAtLast Expands Chain to 17 Locations, Opening New Clinic in Oshawa, Ontario Wal-Mart Supercenter # 1056
10. Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009
11. SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Menopause Often Means Worsening Cholesterol 2Health News:Menopause Often Means Worsening Cholesterol 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:New Board Gains Control of U.S. Shanghai Chemical Corporation 2Health News:Surgery on beating heart thanks to robotic helping hand 2Health News:Repeat of Fire Tragedy in Chicago High-Rise Should Have Been Prevented 2Health News:Repeat of Fire Tragedy in Chicago High-Rise Should Have Been Prevented 3Health News:Repeat of Fire Tragedy in Chicago High-Rise Should Have Been Prevented 4
Breaking Medicine Technology:DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Mercury in Mackenzie River delta dramatically higher than previously believed 49085 1Mercury in Mackenzie River delta dramatically higher than previously believed 49085 2IUPUI study finds living near fast food outlet not a weighty problem for kids 8861 1IUPUI study finds living near fast food outlet not a weighty problem for kids 8861 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 1Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 3